Literature DB >> 34237952

Global trends and hotspots in research of carbapenem-resistant Enterobacteriaceae (CRE): a bibliometric analysis from 2010 to 2020.

Han Zhong1, Fang Chen2, Yu-Jie Li3, Xian-Yuan Zhao3, Zai-Li Zhang2, Zhi-Chun Gu2, Yue-Tian Yu3.   

Abstract

BACKGROUND: Infectious disease caused by carbapenem-resistant Enterobacteriaceae (CRE) has become one of the most serious challenges due to its high morbidity and mortality and research on it has aroused great concern worldwide in the last decade. Thus, a bibliometric analysis of relevant publications is needed to identify the situation of current investigations and prioritize the future research areas.
METHODS: The current study retrieved articles related to CRE published between 2010 and 2020 from the Web of Science core collection database. The search strategy syntax included "carbapenem-resistant Enterobacteriaceae", "carbapenem-resistant Klebsiella pneumoniae", "carbapenemase producing Enterobacteriaceae" and "carbapenemase producing Klebsiella pneumoniae" which were searched in both Medical Subject Headings (MeSH) and titles. A bibliometric analysis was conducted using VOSviewer, Bibliographic Item Co-Occurrence Matrix Builder, gCLUTO and other machine learning tools. Key words, subject terms, contributions as well as collaborations were assessed. Moreover, hot off the press and future research trends were demonstrated.
RESULTS: A total of 1,671 publications on CRE were finally included in the bibliometric analysis and 5 related theme clusters were identified which mainly focused on epidemiology, resistance mechanisms, antibiotics treatment and infection control. A total of 142 keywords occurred more than 5 times and the most frequent keyword was "carbapenem-resistant Enterobacteriaceae" with 247 occurrences and a total link strength of 559. The output on CRE has gradually increased during the last decade, and the USA has made the greatest contribution due to the 533 research papers. Agents that act against CRE, especially ceftazidime-avibactam (occurrences, 85; average publication year, 2018.26), and the early detection of CRE by genome sequencing techniques (occurrences, 97; average publication year, 2017.94) were emerging hot topics which would probably attract future research interest.
CONCLUSIONS: The bibliometric analysis revealed that development of antibacterial agents, early etiological detection and genome sequencing techniques were the hotspots and would probably direct the future research directions which would also facilitate a better understanding of the epidemiology of drug-resistant bacteria and implementing the antibiotic stewardship program.

Entities:  

Keywords:  Bibliometric analysis; carbapenem-resistant Enterobacteriaceae (CRE); carbapenemase; hotspot; trends

Mesh:

Substances:

Year:  2021        PMID: 34237952     DOI: 10.21037/apm-21-87

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  4 in total

1.  Abundance of colistin-resistant Escherichia coli harbouring mcr-1 and extended-spectrum β-lactamase-producing E. coli co-harbouring blaCTX-M-55 or -65 with blaTEM isolates from chicken meat in Vietnam.

Authors:  Tatsuya Nakayama; Hien Le Thi; Phong Ngo Thanh; Doan Tran Nguyen Minh; Oanh Nguyen Hoang; Phuong Hoang Hoai; Takahiro Yamaguchi; Michio Jinnai; Phuc Nguyen Do; Chinh Dang Van; Yuko Kumeda; Atsushi Hase
Journal:  Arch Microbiol       Date:  2022-01-15       Impact factor: 2.552

2.  Framework Development for Clinical Comprehensive Evaluation of Drugs-a Study Protocol Using the Delphi Method and Analytic Hierarchy Process.

Authors:  Chi Zhang; Er-Li Ma; Bing-Long Liu; Bin Wu; Zhi-Chun Gu; Hou-Wen Lin
Journal:  Front Pharmacol       Date:  2022-05-19       Impact factor: 5.988

3.  Global research on Clostridium difficile-associated diarrhoea: A visualized study.

Authors:  Sa'ed H Zyoud
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

4.  Global research trend of esophageal squamous cell carcinoma from 2012 to 2022: a bibliometric analysis.

Authors:  Zehua Zhang; Zhuyun Leng; Kang Fang; Mingchuang Sun; Zhaoxing Li; Le Kang; Tao Chen; Meidong Xu
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.